ASTRAZENECA PLC
AZNCFDrugs in Pipeline
162
Phase 3 Programs
112
Upcoming Catalysts
3
Next Catalyst
Jul 8, 2026
18wMarket Overview
Stock performance and key metrics
3 upcoming, 1 past
Duloxetine
Major Depressive Disorder
Paroxetine
Generalized Anxiety Disorder
Puxitatug Samrotecan
Endometrial Cancer
Ticagrelor
Peripheral Artery Disease
Symbicort pMDI
Asthma
Rosuvastatin calcium
Coronary Arteriosclerosis
pramlintide acetate
Overweight
BDA MDI HFO 160/180 μg
Asthma
Rilvegostomig
Biliary Tract Cancer
Tralokinumab
Asthma
Budesonide/formoterol Turbuhaler
Asthma
candesartan cilexetil
Type 1 Diabetes
dacarbazine
Melanoma
AZD9291 80 mg/40 mg
Stage IB-IIIA Non-small Cell Lung Carcinoma
AZD0780
Cardiovascular Disease
savolitinib
Carcinoma
MEDI4736 (Durvalumab)
Advanced Solid Malignancies
Sunitinib
Carcinoma
sitagliptin
Type 2 Diabetes
Carboplatin
Endometrial Cancer
Tozorakimab
Asthma
Metformin XR
Type 2 Diabetes
methotrexate
Squamous Cell Carcinoma of the Head and Neck
Rosuvastatin 20mg
Homozygous Familial Hypercholesterolemia (HoFH)
Aclidinium bromide
Chronic Obstructive Pulmonary Disease
Aclidinium Bromide/Formoterol Fumarate
Chronic Obstructive Pulmonary Disease (COPD)
Olaparib 300mg tablets
Newly Diagnosed
MEDI4736 (Durvalumab)+Tremelimumab
Non-Small-Cell Lung Carcinoma NSCLC
MEDI4736
Ovarian
D961H sachet 10 mg
Gastric Ulcer (GU)
Volrustomig
Unresectable Pleural Mesothelioma
Docetaxel
Non-Small-Cell Lung Carcinoma
BFF MDI 160/9.6 μg BID (320/19.2μg/day)
Asthma
insulin detemir
Type 2 Diabetes Mellitus
Experimental: Tralokinumab
Uncontrolled Asthma
Nab-paclitaxel
Non-small Cell Lung Cancer
BGF MDI 320/14.4/9.6 μg
COPD (Chronic Obstructive Pulmonary Disease)
Dato-DXd
Metastatic Non-small Cell Lung Cancer
TC-5214
Major Depressive Disorder
Fluticasone propionate
Seasonal Allergic Rhinitis
Metoprolol Succinate
High Blood Pressure (Hypertension).
Fulvestrant
Advanced Breast Cancer
Exenatide once weekly suspension
Diabetes Type 2
Ciclesonide Nasal Spray
Rhinitis, Allergic, Seasonal
Tezepelumab
Asthma
Nirsevimab
Lower Respiratory Tract Infection
Experimental: Tezepelumab
Asthma
formoterol
Stable Asthma
Quetiapine Extended Release
Schizophrenia
Tremelimumab
Non Small Cell Lung Cancer NSCLC
enzalutamide
Metastatic Castration-resistant Prostate Cancer
Dapagliflozin 10 mg
Type 2 Diabetes Mellitus
abiraterone acetate
Metastatic Castration-resistant Prostate Cancer
Capivasertib
Triple Negative Breast Neoplasms
Metformin IR
Diabetes Mellitus, Type 2
fostamatinib
Rheumatoid Arthritis
Anastrozole
Breast Neoplasms
Roflumilast
Asthma
metformin
Type 2 Diabetes Mellitus
Rosuvastatin
Aortic Stenosis
Esomeprazole
NSAIDs
Osimertinib
Non-Small Cell Lung Cancer
Formoterol Fumarate
Chronic Obstructive Pulmonary Disease
Exenatide Once Weekly
Type 2 Diabetes Mellitus
Cisplatin
Non-Small Cell Lung Cancer
olaparib
Colorectal Cancer
Dapagliflozin
Type 2 Diabetes Mellitus
Ciclesonide
Asthma
Saxagliptin
Type 2 Diabetes
Quetiapine
Psychotic Disorders
AC2993
Diabetes Mellitus, Non-Insulin-Dependent
Bicalutamide
Prostate Cancer
budesonide/formoterol
Asthma
Quetiapine fumarate
Schizophrenia
Budesonide Turbuhaler (Pulmicort)
Asthma
Saruparib
Metastatic Castration-Sensitive Prostate Cancer
Symbicort Turbuhaler
Asthma
Quetiapine XR
Schizophrenic Disorders
Erlotinib 150/100 mg
Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer
Budesonide/formoterol (Symbicort Turbuhaler)
Chronic Obstructive Pulmonary Disease
Selumetinib
Neurofibromatosis 1
AZD7442
COVID-19
Ropivacaine
Anesthesia,Spinal
Chlorambucil
Untreated Chronic Lymphocytic Leukemia
Acalabrutinib
Phase I: Relapsed or Refractory B-cell Malignancies
HFA MDI
Asthma
Esomeprazole (Nexium)
Gastroesophageal Reflux Disease (GERD)
Durvalumab +Tremelimumab
Non Small Cell Lung Carcinoma NSCLC
Durvalumab
Hepatocellular Carcinoma
Gefitinib
NSCLC
Atorvastatin
Hypercholesterolaemia
Baxdrostat
Primary Hyperaldosteronism
Benralizumab 30 mg SC + Mometasone Furoate
Nasal Polyposis
Sodium Zirconium Cyclosilicate 5g
Hyperkalemia
Datopotamab Deruxtecan
Non-Small Cell Lung Cancer
Capecitabine
Breast Cancer
budesonide/formoterol (Symbicort)
Mild or Moderate Asthma
Seroquel SR
Schizophrenia
NKTR-118
Opioid-Induced Constipation (OIC)
fluticasone/salmeterol
Asthma
Benralizumab
Asthma
Omeprazole
Non-erosive Reflux Disease
Terbutaline Turbuhaler
Asthma
exenatide
Type 2 Diabetes Mellitus
Anifrolumab
Active Systemic Lupus Erythematosus
Lithium
Mania
BGF MDI 320/28.8/9.6 μg
Asthma
Camizestrant
Breast Cancer, Early Breast Cancer
budesonide
Asthma
Tamoxifen
Bone Density
Paclitaxel
Metastatic Breast Cancer
Candesartan
Congestive Heart Failure
AZD9833
Advanced ER-Positive HER2-Negative Breast Cancer
AZD1236
Chronic Obstructive Pulmonary Disease
AZD3480
Alzheimer Disease
AZD3632
Acute Lymphoblastic Leukaemia
Tomudex
Inoperable or Recurrent Rectal Cancer
Adavosertib
Uterine Serous Carcinoma
AZD2171
Gastrointestinal Stromal Tumors
AZD0292
Bronchiectasis With Pseudomonas Aeruginosa Colonization
AZD7798
Moderate to Severe Crohn's Disease
AZD8233
Dyslipidaemia
AZD6765
Depression
AZD1222
COVID-19
AZD4877
Bladder Cancer
AZD0516
Metastatic Prostate Cancer
AZD9291
Non-Small Cell Lung Cancer
AZD6234
Endocrinology
Datopotamab Deruxtecan (Dato-DXd)
Carcinoma, Non-Small-Cell Lung
Verinurad
Heart Failure With Preserved Ejection Fraction (HFpEF)
AZD7624 1.0 mg
Chronic Obstructive Pulmonary Disease COPD
AZD0486
B-cell Acute Lymphoblastic Leukemia (B-ALL)
[18F]AZD4694
Alzheimer's Disease
Tesaglitazar
Type 2 Diabetes
ZD4054
Non Small Cell Lung Cancer
AZD6244
Metastatic Colorectal Cancer
exenatide once monthly suspension
Type 2 Diabetes
Aclidinium bromide and formoterol
Chronic Obstructive Pulmonary Disease (COPD)
Cediranib
Renal Cell Carcinoma
AZD9668
Chronic Obstructive Pulmonary Disease (COPD)
AZD1305
Left Ventricle Function
AZD5148
Clostridioides Difficile Infection
Amivantamab
Non-Small Cell Lung Cancer (NSCLC)
AZD1981
Chronic Obstructive Pulmonary Disease
AZD3355
Reflux Episodes
Zibotentan
Chronic Kidney Disease
CIN-107 2 mg dosing
Primary Aldosteronism
MEDI3506
Diabetic Kidney Disease
AZD4635
Progressive Metastatic Castrate-Resistant Prostate Cancer
AZD9773
Severe Sepsis
AZD2423
Chronic Obstructive Pulmonary Disease
Selumetinib+Docetaxel
Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (Stage IIIB-IV)
CP-675,206 (Tremelimumab)
Colorectal Neoplasms
AZD4604
Asthma
AZD0901
Gastric Cancer
AZD7268
Major Depressive Disorder
CP-675,206
Carcinoma, Non-small-cell Lung
Quetiapine fumarate (Seroquel)
Major Depressive Disorder
RDEA3170
Gout and Asymptomatic Hyperuricemia
AZD5004
Obesity or Overweight
AZD5863
Gastric Cancer
AZD5305
Metastatic Prostate Cancer
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Duloxetine | Phase 3 | Major Depressive Disorder | - | - |
Paroxetine | Phase 3 | Generalized Anxiety Disorder | - | - |
Puxitatug Samrotecan | Phase 3 | Endometrial Cancer | - | - |
Ticagrelor | Phase 3 | Peripheral Artery Disease | - | - |
Symbicort pMDI | Phase 3 | Asthma | - | - |
Rosuvastatin calcium | Phase 3 | Coronary Arteriosclerosis | - | - |
pramlintide acetate | Phase 3 | Overweight | - | - |
BDA MDI HFO 160/180 μg | Phase 3 | Asthma | - | - |
Rilvegostomig | Phase 3 | Biliary Tract Cancer | - | - |
Tralokinumab | Phase 3 | Asthma | - | - |
Budesonide/formoterol Turbuhaler | Phase 3 | Asthma | - | - |
candesartan cilexetil | Phase 3 | Type 1 Diabetes | - | - |
dacarbazine | Phase 3 | Melanoma | - | - |
AZD9291 80 mg/40 mg | Phase 3 | Stage IB-IIIA Non-small Cell Lung Carcinoma | - | - |
AZD0780 | Phase 3 | Cardiovascular Disease | - | - |
savolitinib | Phase 3 | Carcinoma | - | - |
MEDI4736 (Durvalumab) | Phase 3 | Advanced Solid Malignancies | - | - |
Sunitinib | Phase 3 | Carcinoma | - | - |
sitagliptin | Phase 3 | Type 2 Diabetes | - | - |
Carboplatin | Phase 3 | Endometrial Cancer | - | - |
Tozorakimab | Phase 3 | Asthma | - | - |
Metformin XR | Phase 3 | Type 2 Diabetes | - | - |
methotrexate | Phase 3 | Squamous Cell Carcinoma of the Head and Neck | - | - |
Rosuvastatin 20mg | Phase 3 | Homozygous Familial Hypercholesterolemia (HoFH) | - | - |
Aclidinium bromide | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
Aclidinium Bromide/Formoterol Fumarate | Phase 3 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
Olaparib 300mg tablets | Phase 3 | Newly Diagnosed | - | - |
MEDI4736 (Durvalumab)+Tremelimumab | Phase 3 | Non-Small-Cell Lung Carcinoma NSCLC | - | - |
MEDI4736 | Phase 3 | Ovarian | - | - |
D961H sachet 10 mg | Phase 3 | Gastric Ulcer (GU) | - | - |
Volrustomig | Phase 3 | Unresectable Pleural Mesothelioma | - | - |
Docetaxel | Phase 3 | Non-Small-Cell Lung Carcinoma | - | - |
BFF MDI 160/9.6 μg BID (320/19.2μg/day) | Phase 3 | Asthma | - | - |
insulin detemir | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Experimental: Tralokinumab | Phase 3 | Uncontrolled Asthma | - | - |
Nab-paclitaxel | Phase 3 | Non-small Cell Lung Cancer | - | - |
BGF MDI 320/14.4/9.6 μg | Phase 3 | COPD (Chronic Obstructive Pulmonary Disease) | - | - |
Dato-DXd | Phase 3 | Metastatic Non-small Cell Lung Cancer | - | - |
TC-5214 | Phase 3 | Major Depressive Disorder | - | - |
Fluticasone propionate | Phase 3 | Seasonal Allergic Rhinitis | - | - |
Metoprolol Succinate | Phase 3 | High Blood Pressure (Hypertension). | - | - |
Fulvestrant | Phase 3 | Advanced Breast Cancer | - | - |
Exenatide once weekly suspension | Phase 3 | Diabetes Type 2 | - | - |
Ciclesonide Nasal Spray | Phase 3 | Rhinitis, Allergic, Seasonal | - | - |
Tezepelumab | Phase 3 | Asthma | - | - |
Nirsevimab | Phase 3 | Lower Respiratory Tract Infection | - | - |
Experimental: Tezepelumab | Phase 3 | Asthma | - | - |
formoterol | Phase 3 | Stable Asthma | - | - |
Quetiapine Extended Release | Phase 3 | Schizophrenia | - | - |
Tremelimumab | Phase 3 | Non Small Cell Lung Cancer NSCLC | - | - |
enzalutamide | Phase 3 | Metastatic Castration-resistant Prostate Cancer | - | - |
Dapagliflozin 10 mg | Phase 3 | Type 2 Diabetes Mellitus | - | - |
abiraterone acetate | Phase 3 | Metastatic Castration-resistant Prostate Cancer | - | - |
Capivasertib | Phase 3 | Triple Negative Breast Neoplasms | - | - |
Metformin IR | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
fostamatinib | Phase 3 | Rheumatoid Arthritis | - | - |
Anastrozole | Phase 3 | Breast Neoplasms | - | - |
Roflumilast | Phase 3 | Asthma | - | - |
metformin | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Rosuvastatin | Phase 3 | Aortic Stenosis | - | - |
Esomeprazole | Phase 3 | NSAIDs | - | - |
Osimertinib | Phase 3 | Non-Small Cell Lung Cancer | - | - |
Formoterol Fumarate | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
Exenatide Once Weekly | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Cisplatin | Phase 3 | Non-Small Cell Lung Cancer | - | - |
olaparib | Phase 3 | Colorectal Cancer | - | - |
Dapagliflozin | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Ciclesonide | Phase 3 | Asthma | - | - |
Saxagliptin | Phase 3 | Type 2 Diabetes | - | - |
Quetiapine | Phase 3 | Psychotic Disorders | - | - |
AC2993 | Phase 3 | Diabetes Mellitus, Non-Insulin-Dependent | - | - |
Bicalutamide | Phase 3 | Prostate Cancer | - | - |
budesonide/formoterol | Phase 3 | Asthma | - | - |
Quetiapine fumarate | Phase 3 | Schizophrenia | - | - |
Budesonide Turbuhaler (Pulmicort) | Phase 3 | Asthma | - | - |
Saruparib | Phase 3 | Metastatic Castration-Sensitive Prostate Cancer | - | - |
Symbicort Turbuhaler | Phase 3 | Asthma | - | - |
Quetiapine XR | Phase 3 | Schizophrenic Disorders | - | - |
Erlotinib 150/100 mg | Phase 3 | Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer | - | - |
Budesonide/formoterol (Symbicort Turbuhaler) | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
Selumetinib | Phase 3 | Neurofibromatosis 1 | - | - |
AZD7442 | Phase 3 | COVID-19 | - | - |
Ropivacaine | Phase 3 | Anesthesia,Spinal | - | - |
Chlorambucil | Phase 3 | Untreated Chronic Lymphocytic Leukemia | - | - |
Acalabrutinib | Phase 3 | Phase I: Relapsed or Refractory B-cell Malignancies | - | - |
HFA MDI | Phase 3 | Asthma | - | - |
Esomeprazole (Nexium) | Phase 3 | Gastroesophageal Reflux Disease (GERD) | - | - |
Durvalumab +Tremelimumab | Phase 3 | Non Small Cell Lung Carcinoma NSCLC | - | - |
Durvalumab | Phase 3 | Hepatocellular Carcinoma | - | - |
Gefitinib | Phase 3 | NSCLC | - | - |
Atorvastatin | Phase 3 | Hypercholesterolaemia | - | - |
Baxdrostat | Phase 3 | Primary Hyperaldosteronism | - | - |
Benralizumab 30 mg SC + Mometasone Furoate | Phase 3 | Nasal Polyposis | - | - |
Sodium Zirconium Cyclosilicate 5g | Phase 3 | Hyperkalemia | - | - |
Datopotamab Deruxtecan | Phase 3 | Non-Small Cell Lung Cancer | - | - |
Capecitabine | Phase 3 | Breast Cancer | - | - |
budesonide/formoterol (Symbicort) | Phase 3 | Mild or Moderate Asthma | - | - |
Seroquel SR | Phase 3 | Schizophrenia | - | - |
NKTR-118 | Phase 3 | Opioid-Induced Constipation (OIC) | - | - |
fluticasone/salmeterol | Phase 3 | Asthma | - | - |
Benralizumab | Phase 3 | Asthma | - | - |
Omeprazole | Phase 3 | Non-erosive Reflux Disease | - | - |
Terbutaline Turbuhaler | Phase 3 | Asthma | - | - |
exenatide | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Anifrolumab | Phase 3 | Active Systemic Lupus Erythematosus | - | - |
Lithium | Phase 3 | Mania | - | - |
BGF MDI 320/28.8/9.6 μg | Phase 3 | Asthma | - | - |
Camizestrant | Phase 3 | Breast Cancer, Early Breast Cancer | - | - |
budesonide | Phase 3 | Asthma | - | - |
Tamoxifen | Phase 3 | Bone Density | - | - |
Paclitaxel | Phase 3 | Metastatic Breast Cancer | - | - |
Candesartan | Phase 3 | Congestive Heart Failure | - | - |
AZD9833 | Phase 2 | Advanced ER-Positive HER2-Negative Breast Cancer | - | - |
AZD1236 | Phase 2 | Chronic Obstructive Pulmonary Disease | - | - |
AZD3480 | Phase 2 | Alzheimer Disease | - | - |
AZD3632 | Phase 2 | Acute Lymphoblastic Leukaemia | - | - |
Tomudex | Phase 2 | Inoperable or Recurrent Rectal Cancer | - | - |
Adavosertib | Phase 2 | Uterine Serous Carcinoma | - | - |
AZD2171 | Phase 2 | Gastrointestinal Stromal Tumors | - | - |
AZD0292 | Phase 2 | Bronchiectasis With Pseudomonas Aeruginosa Colonization | - | - |
AZD7798 | Phase 2 | Moderate to Severe Crohn's Disease | - | - |
AZD8233 | Phase 2 | Dyslipidaemia | - | - |
AZD6765 | Phase 2 | Depression | - | - |
AZD1222 | Phase 2 | COVID-19 | - | - |
AZD4877 | Phase 2 | Bladder Cancer | - | - |
AZD0516 | Phase 2 | Metastatic Prostate Cancer | - | - |
AZD9291 | Phase 2 | Non-Small Cell Lung Cancer | - | - |
AZD6234 | Phase 2 | Endocrinology | - | - |
Datopotamab Deruxtecan (Dato-DXd) | Phase 2 | Carcinoma, Non-Small-Cell Lung | - | - |
Verinurad | Phase 2 | Heart Failure With Preserved Ejection Fraction (HFpEF) | - | - |
AZD7624 1.0 mg | Phase 2 | Chronic Obstructive Pulmonary Disease COPD | - | - |
AZD0486 | Phase 2 | B-cell Acute Lymphoblastic Leukemia (B-ALL) | - | - |
[18F]AZD4694 | Phase 2 | Alzheimer's Disease | - | - |
Tesaglitazar | Phase 2 | Type 2 Diabetes | - | - |
ZD4054 | Phase 2 | Non Small Cell Lung Cancer | - | - |
AZD6244 | Phase 2 | Metastatic Colorectal Cancer | - | - |
exenatide once monthly suspension | Phase 2 | Type 2 Diabetes | - | - |
Aclidinium bromide and formoterol | Phase 2 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
Cediranib | Phase 2 | Renal Cell Carcinoma | - | - |
AZD9668 | Phase 2 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
AZD1305 | Phase 2 | Left Ventricle Function | - | - |
AZD5148 | Phase 2 | Clostridioides Difficile Infection | - | - |
Amivantamab | Phase 2 | Non-Small Cell Lung Cancer (NSCLC) | - | - |
AZD1981 | Phase 2 | Chronic Obstructive Pulmonary Disease | - | - |
AZD3355 | Phase 2 | Reflux Episodes | - | - |
Zibotentan | Phase 2 | Chronic Kidney Disease | - | - |
CIN-107 2 mg dosing | Phase 2 | Primary Aldosteronism | - | - |
MEDI3506 | Phase 2 | Diabetic Kidney Disease | - | - |
AZD4635 | Phase 2 | Progressive Metastatic Castrate-Resistant Prostate Cancer | - | - |
AZD9773 | Phase 2 | Severe Sepsis | - | - |
AZD2423 | Phase 2 | Chronic Obstructive Pulmonary Disease | - | - |
Selumetinib+Docetaxel | Phase 2 | Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (Stage IIIB-IV) | - | - |
CP-675,206 (Tremelimumab) | Phase 2 | Colorectal Neoplasms | - | - |
AZD4604 | Phase 2 | Asthma | - | - |
AZD0901 | Phase 2 | Gastric Cancer | - | - |
AZD7268 | Phase 2 | Major Depressive Disorder | - | - |
CP-675,206 | Phase 2 | Carcinoma, Non-small-cell Lung | - | - |
Quetiapine fumarate (Seroquel) | Phase 2 | Major Depressive Disorder | - | - |
RDEA3170 | Phase 2 | Gout and Asymptomatic Hyperuricemia | - | - |
AZD5004 | Phase 2 | Obesity or Overweight | - | - |
AZD5863 | Phase 2 | Gastric Cancer | - | - |
AZD5305 | Phase 2 | Metastatic Prostate Cancer | - | - |